A Phase I, First in Human Trial of University of Queensland's (UQ) COVID-19 Vaccine in Healthy Volunteers
Latest Information Update: 31 Mar 2021
At a glance
- Drugs UQ CSL V451 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; First in man; Pharmacodynamics
- 08 Nov 2020 According to a CSL media release, the decision to proceed to the next clinical trial stage will be made once Phase 1 data has been released and analysed.
- 08 Sep 2020 According to a CSL media release, the company expects this study should prove to be successful towards the end of this year
- 20 Jul 2020 New trial record